Shehzahdi Moonshiمشاهده پروفایل
پژوهشگر ارشد
Dr. Shehzahdi Moonshi is a Postdoctoral Research Fellow at the Frazer Institute, part of the Faculty of Health, Medicine and Behavioural Sciences at the University of Queensland. Her research focuses on advanced biomedical applications of nanotechnology, drug delivery systems, and regenerative medicine. She specializes in developing novel nanomaterials for therapeutic and diagnostic purposes, with a particular emphasis on cancer theranostics, atherosclerosis modeling, and stem cell therapies. Her work integrates microfluidic devices, hydrogel-based models, and biomaterials to address complex biomedical challenges. Dr. Moonshi’s research spans multiple interdisciplinary areas, including nanomedicine, biomedical engineering, and cellular therapy. Her contributions include advancements in nanoparticle design for targeted drug delivery, hydrogel-based 3D models for disease simulation, and placenta-derived mesenchymal stem cells for clinical applications. She collaborates extensively with researchers in materials science and medical imaging to innovate solutions for inflammatory diseases, cardiovascular disorders, and cancer treatment. Her publications highlight cutting-edge techniques such as 19F MRI contrast agents, dual-metal oxide nanocomposites, and polysuccinimide-based drug carriers. These studies underscore her focus on translating laboratory discoveries into clinical relevance. Dr. Moonshi is actively involved in supervising research projects and welcomes potential students to collaborate on her initiatives. While no specific grants or awards are listed, her prolific output in high-impact journals like Lab on a Chip , Biomaterials Science , and Advanced Biology reflects her significant contributions to biomedical research. Her work is pivotal in advancing nanotechnology-driven therapies and diagnostic tools for global health challenges.


